Law and regulation

Salters Cartage owner cries poor while nobbling rivals. By Victoria Young

See details.

AFT Pharmaceuticals posts $11 mln first-half loss after boosting R&D spend, launching OTC products

Fiona Rotherham
Wed, 23 Nov 2016

By Fiona Rotherham Nov. 24 (BusinessDesk) - AFT Pharmaceuticals, the Auckland-based drug-maker, widened its first-half loss to $11 million from $5.8 million after ramping up research and development and launching over-the-counter products in Australia and Singapore. The figures confirm a market trading update the company supplied earlier this month. Cash on hand dropped to $16 million from $28 million the previous year and the company said it had the financial flexibility to increase cash reserves with further drawn downs available on its...

Use the information you’ve already given Google to create your subscription.

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Shift72 profitable after 740% covid growth
Henry Burrell | Mon, 30 Nov 2020

Chief executive of the Kiwi video streaming software company explains how he’s quadrupled his workforce to serve the global film festival market.

Primary Sector
Flying kiwi hitting export returns
Rebecca Howard | Mon, 30 Nov 2020

The kiwi dollar is more than 15 cents higher than the covid low.

Where can you put your money at present?
Brian Gaynor | Sat, 28 Nov 2020

In a low interest rate environment and with residential property running hot, where does today's investor look for other sources of blue sky?

Looking to future-proof your business management skills?

Job candidates who have the knowledge and skills to manage strategy, data and communications in an agile fashion will undoubtedly have a competitive advantage.

CFDs: An alternative to traditional stockmarket investing

One of the unusual side-effects of the financial crisis caused by the covid-19 pandemic has been the explosion in online investment trading.